Search clinical trials for: tigilanol tiglate

Total 36 results

QBiotics Group Limited

Recruiting

A Clinical Study to Investigate the Efficacy of Tigilanol Tiglate Directly in Head and Neck Cancer

Head and Neck Cancer

United Kingdom, Australia
QBiotics Group Limited

Terminated

A Trial of Intratumoural Tigilanol Tiglate in Adult Participants With Stage IIIB to IV M1c Melanoma

Melanoma

Australia
QBiotics Group Limited

Recruiting

A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma

Soft Tissue Sarcoma

United States
QBiotics Group Limited
Merck Sharp & Dohme LLC

Terminated

A Trial of Tigilanol Tiglate in Combination With Pembrolizumab in Stage IIIB to IV M1c-melanoma

Melanoma

Australia
Riphah International University

Recruiting

Effects of Pilates Training on Physical Performance of Cricketers

Core Strengthening

Pakistan
Riphah International University

Recruiting

Effects of Pilates and Burpees Exercises in Core Strengthening and Dynamic Balance.

Sports Physical Therapy

Pakistan
Octapharma

Completed

Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Wilate in Previously Treated Paediatric Patients With Severe Haemophilia A

Severe Hemophilia A

Russian Federation, Ukraine
University of California, Davis

Terminated

INdividualized ITI Based on Fviii(ATE) Protection by VWF (INITIATE)

Hemophilia A | Hemophilia A With Inhibitor

United States
Cairo University
Amira Hassan Abdelaziz; Soheir Mahmoud El-Kosery

Completed

Kinesiotaping Versus Pilate Exercises

Exercise | Dysmenorrhea

Egypt
Octapharma

Completed

Surveillance of Safety and Efficacy of Wilate in Patients With Von Willebrand Disease

Von Willebrand Disease

United States, Canada, Sweden, Spain, Uruguay, United Kingdom, Portugal, Argentina, Czechia, Germany
University Hospital, Basel, Switzerland

Recruiting

Enhancement of the Haemostatic Effect of Platelets in the Presence of High Normal Concentrations of Von Willebrand Factor (Will-Plate)

Bleeding

Switzerland
Octapharma

Active, not recruiting

Efficacy, PK, Immunogenicity and Safety of Wilate in Severe Von Willebrand Disease VWD) Patients <6 Years of Age

Von Willebrand Disease

United States, Moldova, Republic of, Czechia, Germany, North Macedonia, Russian Federation, Ukraine
Octapharma

Terminated

Immune Tolerance Induction in Haemophilia A Patients Using Wilate or Nuwiq (PREVAIL)

Hemophilia A

Canada
Dr Milutin Bulajic

Completed

Assessing Endoloop-assisted Polypectomy in Patients With Antiplatelet Therapy

Colorectal Polyp
Cairo University

Not yet recruiting

Pilate Mat Exercise Versus Muscle Energy Technique on Chronic Non Specific Low Back Pain (MET-LBP)

Chronic Non Specific Low Back Pain
Albert Einstein Healthcare Network
Merck Sharp & Dohme LLC; Davita Clinical Research

Withdrawn

A Prospective Cohort Study to Improve HCV Care in Dialysis Patients (MATCH-D)

Hepatitis C
Armed Forces Hospital, Pakistan

Unknown

Role of Citicoline in Treatment of Newborns With Hypoxic Ischemic Encephalopathy (citicoline)

Hypoxic-Ischemic Encephalopathy

Pakistan
Octapharma

Completed

Clinical Study to Investigate the Efficacy and Safety of Wilate During Prophylaxis in Previously Treated Patients With VWD

Von Willebrand Diseases

Lebanon, Croatia, United States, Belarus, Bulgaria, Hungary, Russian Federation, Ukraine
University of Athens

Unknown

Home Blood Pressure in Hypertension Management (HBP10)

Essential Hypertension

Greece
Octapharma

Completed

Clinical Study to Investigate the PK, Efficacy, and Safety of Wilate in Patients With Severe Hemophilia A

Severe Hemophilia A

Bulgaria, Poland, Hungary, Romania, Russian Federation
Unity Health Toronto

Not yet recruiting

A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients With VWD (EMPOWER)

Von Willebrand Diseases
Cairn Diagnostics
Baylor College of Medicine; Medical College of Wisconsin

Recruiting

Establishing a Pediatric Reference Range for the 13C-Spirulina Gastric Emptying Breath Test (GEBT)

Gastroparesis

United States
Emory University
Octapharma

Recruiting

Treatment of Hemophilia A Patients With FVIII Inhibitors (MOTIVATE)

Hemophilia A

United States, Germany
City of Hope Medical Center
CSL Behring; Grifols Therapeutics LLC; Grifols Biologicals, LLC; Charta Foundation and other collaborators

Completed

Rescue Immunotolerance Study in Induction of Immune Tolerance (ITI)-Experienced Patients (RES.I.S.T. Experienced) (RESIST EXP)

Severe Hemophilia A

United States
University of Florida
National Center for Advancing Translational Sciences (NCATS)

Completed

Race-Specific Propofol Titration to Effect for Procedural Sedation

Unconsciousness | Hypoxemia | Apnea, Postanesthetic | Sedative Overdose

United States
Duke University
Bausch & Lomb Incorporated

Completed

Re-implantation of a Fluocinolone Acetonide Implant for Non-infectious Uveitis Affecting the Posterior Segment

Uveitis

United States
Drugs for Neglected Diseases

Unknown

Short Course Regimens for Treatment of PKDL (Sudan)

PKDL - Post-Kala-Azar Dermal Leishmanioid

Sudan
Novo Nordisk A/S

Terminated

Effect of Insulin Detemir on Use of Energy in Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United Kingdom
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)

Completed

Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment

Cancer

United States
Colgate Palmolive

Completed

Collection of Gingival Crevicular Fluid From Periodontitis Patients

Gingival Diseases

United States
Bloodworks
Ergomed; Octapharma; Mary M. Gooley Hemophilia Center

Recruiting

Von Willebrand Factor in Pregnancy (VIP) Study (VIP)

Von Willebrand Diseases

United States
Johns Hopkins Bloomberg School of Public Health
National Heart, Lung, and Blood Institute (NHLBI); CAMP Steering Committee

Completed

Childhood Asthma Management Program (CAMP) Phases I (Trial), II (CAMPCS), III (CAMPCS/2), and IV (CAMPCS/3) (CAMP)

Lung Diseases | Asthma
City of Hope Medical Center
CSL Behring; Grifols Therapeutics LLC; Grifols Biologicals, LLC; Charta Foundation and other collaborators

Withdrawn

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive (RESIST NAIVE)

Severe Hemophilia A
University of Vigo
Bayer; Hospital Clinico Universitario de Santiago

Terminated

Comparison of Awakening Versus Bedtime Dosing of Aspirin in Pre-Hypertension or Mild Essential Hypertension

High-Normal Blood Pressure | Mild Essential Hypertension

Spain
University of the Philippines

Completed

Changes in Vital Signs and Pupil Diameter Related to Pharmacologic Mydriasis in Premature Infants: A Randomized Double Blind Clinical Study

Retinopathy of Prematurity
National Cancer Institute (NCI)

Recruiting

Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer

Recurrent Nasopharyngeal Carcinoma | Stage IV Nasopharyngeal Carcinoma AJCC v8 | Metastatic Nasopharyngeal Carcinoma

United States, China

Search clinical trials for: tigilanol tiglate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations